PGx Over-hyped, Large Studies of Field s Value Sorely Needed, Says UK Royal Society Researcher | GenomeWeb

Personalized medicine is "over-hyped" in the mind of the public and healthcare policy makers as a result of media reports, opined David Weatherall, co-author of a new report from the UK Royal Society on the subject, in an interview with Pharmacogenomics Reporter this week, echoing similar public comments Genzyme's Robert Yocher made about the US media. The US Food and Drug Administration's Larry Lesko warned in May against the possibility that over-exuberance could trip up the technology's adoption.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.